Latest filing published 15 May 2020 for Lyra Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Soleus Private Equity GP I, LLC: trading record in brief
This profile gathers the share dealings of Soleus Private Equity GP I, LLC in Lyra Therapeutics, Inc. We count 5 filings, every one of them for a trade on 5 May 2020.
On the open market, the record shows 1 purchase worth €2.3M and 1 sale worth €250k. Netting one side against the other leaves €2.0M of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
On 15 May 2020 came the latest disclosure, a transaction in Lyra Therapeutics, Inc. The clock since the last published purchase (15 May 2020) now reads 2,369 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 10 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Soleus Private Equity GP I, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 338,330 shares0Common StockSEC:0001493152-20-009217:0
- 104,608 shares0Common StockSEC:0001493152-20-009217:1
- 31,382 shares@ US$8.63Common StockSEC:0001493152-20-009217:2
- 16,909 shares@ US$16.00Common StockSEC:0001493152-20-009217:3
- 155,000 shares@ US$16.00Common StockSEC:0001493152-20-009217:4Canonical exit: 3 Aug 2020 (T+90)
5 of 5 declarations